133 related articles for article (PubMed ID: 2047815)
1. Comparison of methods for the biomonitoring of nurses handling antitumor drugs.
Thiringer G; Granung G; Holmén A; Högstedt B; Järvholm B; Jönsson D; Persson L; Wahlström J; Westin J
Scand J Work Environ Health; 1991 Apr; 17(2):133-8. PubMed ID: 2047815
[TBL] [Abstract][Full Text] [Related]
2. Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs.
Barale R; Sozzi G; Toniolo P; Borghi O; Reali D; Loprieno N; Della Porta G
Mutat Res; 1985; 157(2-3):235-40. PubMed ID: 4022044
[TBL] [Abstract][Full Text] [Related]
3. Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs.
Stucker I; Hirsch A; Doloy T; Bastie-Sigeac I; Hemon D
Int Arch Occup Environ Health; 1986; 57(3):195-205. PubMed ID: 3957439
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses.
Krepinsky A; Bryant DW; Davison L; Young B; Heddle J; McCalla DR; Douglas G; Michalko K
Environ Mol Mutagen; 1990; 15(2):83-92. PubMed ID: 2407531
[TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking.
Bos RP; Leenaars AO; Theuws JL; Henderson PT
Int Arch Occup Environ Health; 1982; 50(4):359-69. PubMed ID: 6757139
[TBL] [Abstract][Full Text] [Related]
6. Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials.
DeMéo MP; Mérono S; DeBaille AD; Botta A; Laget M; Guiraud H; Duménil G
Int Arch Occup Environ Health; 1995; 66(6):363-8. PubMed ID: 7782118
[TBL] [Abstract][Full Text] [Related]
7. Handling of cytostatic drugs and urine mutagenesis.
Poyen D; De Méo MP; Botta A; Gouvernet J; Duménil G
Int Arch Occup Environ Health; 1988; 61(3):183-8. PubMed ID: 3220590
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.
Rekhadevi PV; Sailaja N; Chandrasekhar M; Mahboob M; Rahman MF; Grover P
Mutagenesis; 2007 Nov; 22(6):395-401. PubMed ID: 17855733
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal aberrations, sister chromatid exchanges, and urinary thioethers in nurses handling antineoplastic drugs.
Sarto F; Trevisan A; Tomanin R; Canova A; Fiorentino M
Am J Ind Med; 1990; 18(6):689-95. PubMed ID: 2264567
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity in urine from nurses handling cytostatic agents.
Benhamou S; Callais F; Sancho-Garnier H; Min S; Courtois YA; Festy B
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1489-93. PubMed ID: 3595674
[TBL] [Abstract][Full Text] [Related]
11. Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics.
Burgaz S; Karahalil B; Bayrak P; Taşkin L; Yavuzaslan F; Bökesoy I; Anzion RB; Bos RP; Platin N
Mutat Res; 1999 Feb; 439(1):97-104. PubMed ID: 10029685
[TBL] [Abstract][Full Text] [Related]
12. Sister chromatid exchanges and chromosome aberrations in lymphocytes of nurses handling antineoplastic drugs.
Goloni-Bertollo EM; Tajara EH; Manzato AJ; Varella-Garcia M
Int J Cancer; 1992 Feb; 50(3):341-4. PubMed ID: 1735601
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs.
Mahmoodi M; Soleyman-Jahi S; Zendehdel K; Mozdarani H; Azimi C; Farzanfar F; Safari Z; Mohagheghi MA; Khaleghian M; Divsalar K; Asgari E; Rezaei N
Drug Chem Toxicol; 2017 Apr; 40(2):235-240. PubMed ID: 27461518
[TBL] [Abstract][Full Text] [Related]
14. A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project.
Moretti M; Bonfiglioli R; Feretti D; Pavanello S; Mussi F; Grollino MG; Villarini M; Barbieri A; Ceretti E; Carrieri M; Buschini A; Appolloni M; Dominici L; Sabatini L; Gelatti U; Bartolucci GB; Poli P; Stronati L; Mastrangelo G; Monarca S
BMC Public Health; 2011 Mar; 11():195. PubMed ID: 21450074
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of genotoxic risk of handling cytostatic drugs in clinical pharmacy practice.
Guinée EP; Beuman GH; Hageman G; Welle IJ; Kleinjans JC
Pharm Weekbl Sci; 1991 Apr; 13(2):78-82. PubMed ID: 1870947
[TBL] [Abstract][Full Text] [Related]
16. Analysis of sister chromatid exchange and micronuclei in peripheral blood lymphocytes of nurses handling cytostatic drugs.
Kasuba V; Rozgaj R; Garaj-Vrhovac V
J Appl Toxicol; 1999; 19(6):401-4. PubMed ID: 10547621
[TBL] [Abstract][Full Text] [Related]
17. Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.
Sessink PJ; Bos RP
Drug Saf; 1999 Apr; 20(4):347-59. PubMed ID: 10230582
[TBL] [Abstract][Full Text] [Related]
18. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.
Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ
Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554
[TBL] [Abstract][Full Text] [Related]
19. Comparison among five mutagenicity assays in workers producing polyurethane foams.
Holmén A; Akesson B; Hansén L; Frithiof J; Mitelman F; Karlsson A; Persson L; Welinder H; Skerfving S; Högstedt B
Int Arch Occup Environ Health; 1988; 60(3):175-9. PubMed ID: 3384483
[TBL] [Abstract][Full Text] [Related]
20. Urinary biological monitoring markers of anticancer drug exposure in oncology nurses.
Newman MA; Valanis BG; Schoeny RS; Hee SQ
Am J Public Health; 1994 May; 84(5):852-5. PubMed ID: 8179062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
